Growth inhibitors promote differentiation of insulin-producing tissue from embryonic stem cells. - Wikidata - wikimedia - TriplyDB

Growth inhibitors promote differentiation of insulin-producing tissue from embryonic stem cells.

Growth inhibitors promote differentiation of insulin-producing tissue from embryonic stem cells.

http://www.wikidata.org/entity/Q34415516

about

PAX4 enhances beta-cell differentiation of human embryonic stem cells Differentiation of insulin-producing cells from human neural progenitor cells Directed differentiation of rhesus monkey ES cells into pancreatic cell phenotypes Diabetes treatment: A rapid review of the current and future scope of stem cell research Recent developments in β-cell differentiation of pluripotent stem cells induced by small and large molecules Role of nucleostemin in growth regulation of gastric cancer, liver cancer and other malignancies Use of Mesenchymal Stem Cell-Conditioned Medium to Activate Islets in Preservation Solution WNT and beta-catenin signalling: diseases and therapies Covalent histone modifications underlie the developmental regulation of insulin gene transcription in pancreatic beta cells.Functional evaluation of ES cell-derived endodermal populations reveals differences between Nodal and Activin A-guided differentiation.Brain repair by cell replacement and regeneration.A pituitary gene encodes a protein that produces differentiation of breast and prostate cancer cells Islet-like clusters derived from mesenchymal stem cells in Wharton's Jelly of the human umbilical cord for transplantation to control type 1 diabetes.Slow and steady is the key to beta-cell replication.Current status of islet cell replacement and regeneration therapy.Adipose stem cell-based regenerative medicine for reversal of diabetic hyperglycemia.Differentiation of mouse embryonic stem cells into endoderm without embryoid body formation Embryonic pig liver, pancreas, and lung as a source for transplantation: optimal organogenesis without teratoma depends on distinct time windows.Stem cells as a therapeutic target for diabetes.Altered insulin receptor signalling and β-cell cycle dynamics in type 2 diabetes mellitus Insulin-producing cells from human adipose tissue-derived mesenchymal stem cells detected by atomic force microscope.Evaluating protocols for embryonic stem cell differentiation into insulin-secreting beta-cells using insulin II-GFP as a specific and noninvasive reporter.GLP-1 could improve the similarity of IPCs and pancreatic beta cells in cellular ultrastructure and function.Methods to assess stem cell lineage, fate and function Insulin-producing cells derived from human embryonic stem cells: comparison of definitive endoderm- and nestin-positive progenitor-based differentiation strategies Maturation of stem cell-derived beta-cells guided by the expression of urocortin 3.The role of glucose, serum, and three-dimensional cell culture on the metabolism of bone marrow-derived mesenchymal stem cells.Nestin-positive progenitor cells isolated from human fetal pancreas have phenotypic markers identical to mesenchymal stem cells Teratoma formation leads to failure of treatment for type I diabetes using embryonic stem cell-derived insulin-producing cells.Efficient and simple production of insulin-producing cells from embryonal carcinoma stem cells using mouse neonate pancreas extract, as a natural inducer.Alternative sources of beta cells for cell therapy of diabetes.Combinatorial treatment of bone marrow stem cells and stromal cell-derived factor 1 improves glycemia and insulin production in diabetic mice.Insulin-producing surrogate β-cells from embryonic stem cells: are we there yet?Engineered commensal bacteria reprogram intestinal cells into glucose-responsive insulin-secreting cells for the treatment of diabetes.Hepatic insulin gene therapy in insulin-dependent diabetes mellitus.Pancreatic islet cell therapy for type I diabetes: understanding the effects of glucose stimulation on islets in order to produce better islets for transplantation.Potential of embryonic and adult stem cells in vitro.Cell therapies for type 1 diabetes mellitus.Differentiation of human labia minora dermis-derived fibroblasts into insulin-producing cells Transplantation: focus on kidney, liver and islet cells.

P2860

Q21092222-6129D7A6-7D05-4D43-B8C8-ACBBAEB751AA Q21092394-9CEFE454-DC2F-4EFA-BD5B-4B7152608489 Q24802550-0245F10D-FFAC-40E9-932F-5D39CCC71C7C Q26748645-D5275E30-D34C-441E-B551-30FF1C4B6F96 Q26825664-02EB8062-4287-4F2A-A05B-72FEB4A2AE08 Q28258905-CBD54993-BD21-4CDF-A96F-6184494F7FD9 Q28601697-1C3450AE-044B-4B1A-8FB8-185B196FBACD Q29616159-DA94732C-D1D3-47CD-8CC8-A1E436154534 Q30310799-F14720F9-9AF0-438F-9618-EC6E3AFCB6EA Q30533879-E0425B28-B8D0-4870-BECB-888C27E98A40 Q31146895-97C3AA0C-7DDA-49F3-90C3-18FD60F7F346 Q33197120-1A0AFD98-3E1F-406A-BA25-473AEF03F2A0 Q33314921-A59737F6-8681-4C45-BB4A-83A2FC706E6A Q33647542-12B66CA1-D135-4C5B-90DE-D01986AA7BEA Q33738705-FCD245E7-8D4B-4710-A01E-E1DBE308CBC2 Q33759539-12DDF49D-53F4-4147-B8B5-1414D16DE189 Q33770138-FC9063C2-DA11-4546-B237-1B3E13F33711 Q33844988-55FA34B2-CC54-4E5B-B75F-A5FA5769902A Q33982394-38CA49DA-DF05-4B8D-875F-A39D1EDA265E Q34091221-475F5C34-444D-45A0-B6A0-4F1CC77B66E6 Q34186756-48C17ED2-5159-4452-B177-F5B744452805 Q34374773-9BF5D1E3-0C85-4CC0-900D-20B2EACFB0D6 Q34647309-E9C3B536-0DDB-44D0-9716-BC8C3F3C4098 Q34807143-1389DE52-D19E-48E9-9D8A-C53DEB388465 Q34951717-D4E6B421-3D8A-4E59-8BF0-39A3DFB90997 Q34972402-585220F1-7168-4DB7-A4C5-B1571904EA21 Q34986559-6E258BB3-0F6F-49F2-93FE-351E63A1F5C1 Q35010291-491F1C47-A35C-4C6C-B6B6-FBAB91D2948D Q35083934-E880BE49-FF92-4623-B807-68174828FCEC Q35116178-BE2E994B-CCC4-4EF5-A824-091229C8B700 Q35157499-90F57248-0E20-4F0E-8D3E-6341B9A92BB5 Q35209577-2D259709-DD37-49FD-B859-7C7917611C68 Q35285830-3303C199-3BE9-4F9B-A83D-1F161B61D19E Q35532294-F565A736-D3F4-47D3-A7CA-BCFBD721B446 Q35544053-506FCAB0-2CA4-453D-BEE5-A829BDDFAB2A Q35585661-3A3AFF23-6BA0-4F95-8066-4923BFCB0CA4 Q35605784-0156EC92-313C-4437-A157-CB556D769D91 Q35684842-E3E2BF1D-FA1B-4CC2-B31E-FEF7CF7B8262 Q35752093-392E6C68-E5D8-4F39-80BF-F4CF6584DEED Q35767225-D6A7AD5C-4347-4302-A2F9-8D5DEB7A1121

P2860

Growth inhibitors promote differentiation of insulin-producing tissue from embryonic stem cells.

http://www.wikidata.org/entity/Q34415516

description

2002 nî lūn-bûn

@nan

2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Growth inhibitors promote diff ...... sue from embryonic stem cells.

@ast

Growth inhibitors promote diff ...... sue from embryonic stem cells.

@en

Growth inhibitors promote diff ...... sue from embryonic stem cells.

@nl

type

label

Growth inhibitors promote diff ...... sue from embryonic stem cells.

@ast

Growth inhibitors promote diff ...... sue from embryonic stem cells.

@en

Growth inhibitors promote diff ...... sue from embryonic stem cells.

@nl

prefLabel

Growth inhibitors promote diff ...... sue from embryonic stem cells.

@ast

Growth inhibitors promote diff ...... sue from embryonic stem cells.

@en

Growth inhibitors promote diff ...... sue from embryonic stem cells.

@nl

P1433

Q34415516-405A2C14-EBF8-459D-B008-C02656C0CB32

P1476

Q34415516-EE6B85C4-7471-4275-8B87-5D7899432807

P2093

Q34415516-0453455E-3775-495F-B620-C2747C164348

Q34415516-3A112C9D-78FA-4600-8199-887B9BF8A785

Q34415516-49B678E9-79A7-45EA-A716-4219041C1EDA

Q34415516-57294001-37EC-4AA3-807E-A6556A6FE5CF

Q34415516-659F7C2D-41BD-4BEE-862A-4993E9419281

Q34415516-BE60A546-9639-4785-B379-6439D1C3EFBC

P2860

Q34415516-0002770C-2899-49FC-945B-66086894D77D

Q34415516-04889790-C4F7-449C-BB95-00CDEB62F0EC

Q34415516-0575A793-2A13-4AFD-887C-6D2E267BEC89

Q34415516-10F2FBC9-0D86-4234-9011-93A58B1FCDBE

Q34415516-144E330D-B74E-4BC0-BB65-43134B3A8EA4

Q34415516-1E44D84B-F2F6-48C6-AB25-49A7199891B5

Q34415516-2D0C25E0-5B27-46B9-B166-9CC333C964A7

Q34415516-3A980486-48E3-45B6-85D5-FDD733791CD7

Q34415516-3D0EFDEB-75B9-428B-87C5-3D97BA25C195

Q34415516-3D30CCD7-12F1-4EF3-86E2-4D02768C1175

P304

Q34415516-B22F9921-B313-46F4-AA61-28A7AA370D40

P31

Q34415516-F84A18CF-508D-4DC6-8377-D9CB5C4B2AE6

P356

Q34415516-97B39069-E839-4BEE-AE9A-A927ACD67E32

P407

Q34415516-7CE2E67F-6819-48AF-AAC9-116315C304BC

P433

Q34415516-AB01452D-A9C7-4B8F-B21F-7D2C595ED118

P478

Q34415516-9FA34994-FD8C-49F0-A3F4-8526D30284D8

P577

Q34415516-281E8C4B-606A-45E9-A364-40F11EFD31C4

P5875

Q34415516-95FC6886-E23E-4570-B1E3-4435FF731E61

P698

Q34415516-116A5131-0133-4B3D-973F-F149BA5AF15A

P921

Q34415516-B892FBCB-8DB3-45E6-A16F-15596CEC6471

P932

Q34415516-3EC98345-26D3-4370-907F-E08A2E9C63FA

P356

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Growth inhibitors promote diff ...... sue from embryonic stem cells.

@en

P2093

Bernette C Tsai

http://www.w3.org/2001/XMLSchema#string

Ingrid C Rulifson

http://www.w3.org/2001/XMLSchema#string

Jeremy J Heit

http://www.w3.org/2001/XMLSchema#string

John D Cahoy

http://www.w3.org/2001/XMLSchema#string

Seung K Kim

http://www.w3.org/2001/XMLSchema#string

Yuichi Hori

http://www.w3.org/2001/XMLSchema#string

P2860

Insulin signalling and the regulation of glucose and lipid metabolism

The role of the transcriptional regulator Ptf1a in converting intestinal to pancreatic progenitors

Null mutation of Dlx-2 results in abnormal morphogenesis of proximal first and second branchial arch derivatives and abnormal differentiation in the forebrain

Major species differences between humans and rodents in the susceptibility to pancreatic beta-cell injury

neurogenin3 is required for the development of the four endocrine cell lineages of the pancreas

Nonparametric Estimation from Incomplete Observations

Embryonic stem cell lines derived from human blastocysts

Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen

Loss of Cdk4 expression causes insulin-deficient diabetes and Cdk4 activation results in beta-islet cell hyperplasia

Synthesis and function of 3-phosphorylated inositol lipids

P304

16105-16110

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.252618999

http://www.w3.org/2001/XMLSchema#string

P407

P433

25

http://www.w3.org/2001/XMLSchema#string

P478

99

http://www.w3.org/2001/XMLSchema#string

P577

2002-11-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11027713

http://www.w3.org/2001/XMLSchema#string

P698

12441403

http://www.w3.org/2001/XMLSchema#string

P921

P932

138572

http://www.w3.org/2001/XMLSchema#string